FDA Information Page
Why is it important to know that all these medicines contain acetaminophen?
Because too much can damage your liver.
Acetaminophen is an active ... more>>
Views: 140
Language:
CERVICAL ARTIFICAL DISC RECEIVES FDA APPROVAL State-of-the-art
Press Release
CERVICAL ARTIFICAL DISC RECEIVES FDA APPROVAL
State-of-the-art Surgical Technique Provides Indianapolis Patients An Ideal Alternative ... more>>
Tags: cervical disc,
spinal fusion,
degenerative disc disease,
united states,
fda approval,
the neck,
the prestige,
post approval,
business wire,
food and drug administration,
cervical degenerative disc disease,
spine surgeons,
cervical spine,
spinal disorders,
breast cancer
Views: 2
Language: English
Views: 2
Language: ENGLISH
FDA Organizational Chart
DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
OFFICE OF THE COMMISSIONER
OFFICE OF EQUAL OPPORTUNITY COMMISSIONER OF FOOD AND D ... more>>
Views: 646
Language:
NeurogesX Receives FDA Approval of Qutenza™ (capsaicin) 8% Patch
FOR IMMEDIATE RELEASE
NeurogesX, Inc. Stephen Ghiglieri Chief Financial Officer (650) 358-3310 The Ruth Group Sara Pellegrino (investors) (646) ... more>>
Tags: neuropathic pain,
neurogesx inc,
postherpetic neuralgia,
product candidates,
fda approval,
prescription strength,
united states,
diabetic adults,
single one,
medicinal products,
biopharmaceutical company,
pain management,
conference call,
one-hour treatment,
forward-looking statements
Views: 0
Language: English
STELARA ™ (ustekinumab) Receives FDA Approval For Treatment Of
STELARA ™ (ustekinumab) Receives FDA Approval For Treatment Of Moderate To Severe Plaque Psoriasis With Four-Times-A-Year Maintenance Dosing
First-in ... more>>
Tags: plaque psoriasis,
fda approval,
ortho biotech,
johnson & johnson,
food and drug administration,
psoriasis drug,
doctor right,
united states,
psoriasis area and severity index,
treatment option,
press releases,
today announced,
pharmaceutical news,
fda news,
the treatment
Views: 0
Language: English
Dyax Announces FDA Approval of KALBITOR (ecallantide) for the
Contacts: Ivana Magovčević-Liebisch Executive Vice President Corporate Development and General Counsel (617) 250-5759 imagovcevic@dyax.com Nicole ... more>>
Tags: dyax corp,
hereditary angioedema,
acute attacks,
fda approval,
16 years,
years of age,
the treatment,
hypersensitivity reactions,
business wire,
food and drug administration,
stock quotes,
today announced,
press releases,
rss feeds,
industry news
Views: 0
Language: English